Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 7
2005 3
2006 3
2007 4
2009 3
2010 5
2011 3
2012 4
2013 10
2014 10
2015 4
2016 16
2017 9
2018 14
2019 12
2020 13
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial.
Alotaibi F, Alharbi NK, Rosen LB, Asiri AY, Assiri AM, Balkhy HH, Al Jeraisy M, Mandourah Y, AlJohani S, Al Harbi S, Jokhdar HAA, Deeb AM, Memish ZA, Jose J, Ghazal S, Al Faraj S, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, AlMutairi BM, Al-Dawood A, Abdullah ML, Barhoumi T, Alenazi MW, Almasood A, Holland SM, Arabi YM; Saudi Critical Care Trials Group. Alotaibi F, et al. Among authors: balkhy hh. Influenza Other Respir Viruses. 2023 Mar 21;17(3):e13116. doi: 10.1111/irv.13116. eCollection 2023 Mar. Influenza Other Respir Viruses. 2023. PMID: 36960162 Free PMC article. Clinical Trial.
Establishing a marine monitoring programme to assess antibiotic resistance: A case study from the Gulf Cooperation Council (GCC) region.
Light E, Baker-Austin C, Card RM, Ryder D, Alves MT, Al-Sarawi HA, Abdulla KH, Stahl H, Al-Ghabshi A, Alghoribi MF, Balkhy HH, Joseph A, Hughes A, Quesne WJFL, Verner-Jeffreys DW, Lyons BP. Light E, et al. Among authors: balkhy hh. Environ Adv. 2022 Oct;9:None. doi: 10.1016/j.envadv.2022.100268. Environ Adv. 2022. PMID: 36466197 Free PMC article.
Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels.
Arabi YM, Asiri AY, Assiri AM, Abdullah ML, Aljami HA, Balkhy HH, Al Jeraisy M, Mandourah Y, AlJohani S, Al Harbi S, Jokhdar HAA, Deeb AM, Memish ZA, Jose J, Ghazal S, Al Faraj S, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Hayden FG, Fowler RA, AlMutairi BM, Al-Dawood A, Alharbi NK. Arabi YM, et al. Among authors: balkhy hh. Sci Rep. 2022 Oct 28;12(1):18186. doi: 10.1038/s41598-022-22742-8. Sci Rep. 2022. PMID: 36307462 Free PMC article. Clinical Trial.
Genomic Characterization of Carbapenem-Non-susceptible Pseudomonas aeruginosa Clinical Isolates From Saudi Arabia Revealed a Global Dissemination of GES-5-Producing ST235 and VIM-2-Producing ST233 Sub-Lineages.
Doumith M, Alhassinah S, Alswaji A, Alzayer M, Alrashidi E, Okdah L, Aljohani S; NGHA AMR Surveillance Group; Balkhy HH, Alghoribi MF. Doumith M, et al. Among authors: balkhy hh. Front Microbiol. 2022 Jan 6;12:765113. doi: 10.3389/fmicb.2021.765113. eCollection 2021. Front Microbiol. 2022. PMID: 35069471 Free PMC article.
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial.
Bosaeed M, Balkhy HH, Almaziad S, Aljami HA, Alhatmi H, Alanazi H, Alahmadi M, Jawhary A, Alenazi MW, Almasoud A, Alanazi R, Bittaye M, Aboagye J, Albaalharith N, Batawi S, Folegatti P, Ramos Lopez F, Ewer K, Almoaikel K, Aljeraisy M, Alothman A, Gilbert SC, Khalaf Alharbi N. Bosaeed M, et al. Among authors: balkhy hh. Lancet Microbe. 2022 Jan;3(1):e11-e20. doi: 10.1016/S2666-5247(21)00193-2. Epub 2021 Nov 3. Lancet Microbe. 2022. PMID: 34751259 Free PMC article. Clinical Trial.
Antimicrobial resistance trends of non-fermenter Gram negative bacteria in Saudi Arabia: A six-year national study.
Somily A, Balkhy HH, Enani MAS, Althawadi SI, Alawi M, Al Johani SM, Al Jindan R, AlBarrak A, AlAjlan H, AlAgeel AA, Roushdy HM, Dada HM, Al-Abdely HM. Somily A, et al. Among authors: balkhy hh. J Infect Public Health. 2021 Sep;14(9):1144-1150. doi: 10.1016/j.jiph.2021.07.007. Epub 2021 Jul 15. J Infect Public Health. 2021. PMID: 34358816 Free article.
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
Arabi YM, Asiri AY, Assiri AM, Balkhy HH, Al Bshabshe A, Al Jeraisy M, Mandourah Y, Azzam MHA, Bin Eshaq AM, Al Johani S, Al Harbi S, Jokhdar HAA, Deeb AM, Memish ZA, Jose J, Ghazal S, Al Faraj S, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Al-Hameed F, Al Saedi A, Alharbi NK, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, AlMutairi BM, Hussein MA, Alothman A; Saudi Critical Care Trials Group. Arabi YM, et al. Among authors: balkhy hh. N Engl J Med. 2020 Oct 22;383(17):1645-1656. doi: 10.1056/NEJMoa2015294. Epub 2020 Oct 7. N Engl J Med. 2020. PMID: 33026741 Clinical Trial.
Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia.
Alshamrani MM, El-Saed A, Mohammed A, Alghoribi MF, Al Johani SM, Cabanalan H, Balkhy HH. Alshamrani MM, et al. Among authors: balkhy hh. Infect Control Hosp Epidemiol. 2021 Feb;42(2):149-155. doi: 10.1017/ice.2020.414. Epub 2020 Sep 3. Infect Control Hosp Epidemiol. 2021. PMID: 32880247
126 results